S
KRTX

SignatureFD’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

SignatureFD’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-487
Closed -$154K – 3280
2023
Q4 		$154K Buy
487
+212
+77% +$41.2K ﹤0.01% 907
2023
Q3 		$46.5K Buy
275
+200
+267% +$37.6K ﹤0.01% 1427
2023
Q2 		$16.3K Buy
75
+21
+39% +$4.5K ﹤0.01% 1991
2023
Q1 		$9.81K Sell
54
-4
-7% -$765 ﹤0.01% 2220
2022
Q4 		$11.4K Buy
58
+2
+4% +$429 ﹤0.01% 2083
2022
Q3 		$13K Buy
56
+20
+56% +$4.05K ﹤0.01% 1968
2022
Q2 		$5K Buy
36
+2
+6% +$230 ﹤0.01% 2482
2022
Q1 		$4K Buy
34
+27
+386% +$3.04K ﹤0.01% 2634
2021
Q4 		$1K Hold
7
– – ﹤0.01% 3040
2021
Q3 		$1K Buy
+7
New +$808 ﹤0.01% 2969

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

SignatureFD's KRTX Position: Q1 2024 in Review

SignatureFD sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 487 shares — an estimated $154K sold.

SignatureFD first reported a position in KRTX in Q3 2021 and held it in 10 quarters. The position peaked at $154K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • SignatureFD reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SignatureFD sold 487 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $154K.
  • SignatureFD first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • SignatureFD's Karuna Therapeutics, Inc. Common Stock position peaked at $154K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.